Overview

Study of Behavioral Modification Program and Mirabegron to Improve Urinary Urgency in Multiple Sclerosis

Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment with Mirabegron will improve urinary urgency control beyond that achieved with pelvic floor exercises alone
Phase:
Phase 4
Details
Lead Sponsor:
Theodore R. Brown, MD MPH
Collaborator:
Astellas Pharma Inc
Treatments:
Mirabegron